Tristel (TSTL) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Oct 2023 07:00 AM
RNS
Additional Investor Presentation
10 Oct 2023 04:45 PM
RNS
Exercise of Share Options and Total Voting Rights
02 Oct 2023 11:50 AM
RNS
Holding(s) in Company
28 Sep 2023 02:00 PM
RNS
Exercise of Share Options and Total Voting Rights
26 Sep 2023 02:40 PM
RNS
Holding(s) in Company
25 Sep 2023 08:40 AM
RNS
Holding(s) in Company
22 Sep 2023 03:40 PM
RNS
Holding(s) in Company
12 Sep 2023 07:00 AM
RNS
Notice of Results
04 Sep 2023 07:00 AM
RNS
Health Canada regulatory approval submission
31 Jul 2023 08:05 AM
RNS
Holding(s) in Company
28 Jul 2023 08:28 AM
RNS
Director/PDMR Shareholding
25 Jul 2023 07:00 AM
RNS
Trading update
12 Jul 2023 07:00 AM
RNS
Shareholder Open Day and Notice of Trading Update
10 Jul 2023 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
26 Jun 2023 07:00 AM
RNS
Director/PDMR Shareholding
22 Jun 2023 04:01 PM
RNS
Holding(s) in Company
16 Jun 2023 07:00 AM
RNS
Exercise of Share Options and Total Voting Rights
14 Jun 2023 04:10 PM
RNS
Holding(s) in Company
06 Jun 2023 05:00 PM
RNS
Exercise of Share Options and Total Voting Rights
05 Jun 2023 10:00 AM
RNS
Analyst and Investor presentation
05 Jun 2023 07:00 AM
RNS
FDA De Novo approval
28 Mar 2023 11:30 AM
RNS
Issue of Equity
27 Mar 2023 07:00 AM
RNS
Successful submission of additional data to US FDA
14 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
14 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
14 Mar 2023 09:30 AM
RNS
Issue of Equity
22 Feb 2023 04:30 PM
RNS
Issue of Equity
20 Feb 2023 07:00 AM
RNS
Half-year Report
30 Jan 2023 07:00 AM
RNS
Notice of Results and Investor presentation
14 Dec 2022 11:00 AM
RNS
Result of AGM - Replacement
13 Dec 2022 07:00 AM
RNS
Issue of Equity
12 Dec 2022 11:26 AM
RNS
Result of AGM
12 Dec 2022 07:00 AM
RNS
AGM Statement
02 Nov 2022 01:50 PM
RNS
Holding(s) in Company
25 Oct 2022 07:00 AM
RNS
Audited Preliminary Results
06 Oct 2022 09:15 AM
RNS
Issue of Equity
04 Oct 2022 12:00 PM
RNS
Appointment of new Company Secretary
04 Oct 2022 07:00 AM
RNS
Notice of Results & Investor Presentation
29 Sep 2022 01:00 PM
RNS
North America update
30 Aug 2022 07:00 AM
RNS
Holding(s) in Company
22 Jul 2022 01:05 PM
RNS
Director/PDMR Shareholding
21 Jul 2022 10:15 AM
RNS
Holding(s) in Company
18 Jul 2022 04:41 PM
RNS
Second Price Monitoring Extn
18 Jul 2022 04:35 PM
RNS
Price Monitoring Extension
18 Jul 2022 07:00 AM
RNS
Trading update and special dividend
30 Jun 2022 07:00 AM
RNS
De Novo FDA submission for Tristel Duo ULT
20 Jun 2022 10:00 AM
RNS
Shareholder Open Day & Notice of Trading update
07 Jun 2022 01:15 PM
RNS
Holding(s) in Company
04 May 2022 07:00 AM
RNS
Investor Presentation
03 May 2022 12:30 PM
RNS
Holding(s) in Company

Tristel plc is a global infection prevention company focused on manufacturing and supplying products using its proprietary chlorine dioxide (ClO2) chemistry, with a focus on medical device decontamination and surface disinfection.

Tristel share price launched at 46p in 2005.

UK 100

Latest directors dealings